vimarsana.com

Page 7 - ஒன்றுபட்டது நாடுகள் தரகு ஆன் போதை மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Christmas wish come true : CBD industry celebrates as EC resumes Novel Food applications

‘A Christmas wish come true’: CBD industry celebrates as EC resumes Novel Food applications More good news for the CBD industry. The European Commission has abandoned its plans to classify non-synthetic CBD a narcotic and resumed Novel Food applications for edible CBD products. The move came after the European Court of Justice ruled that CBD is not a narcotic drug as it “does not appear to have any psychotropic effect or any harmful effect on human health”.​ This verdict, which related to the prosecution of French e-cigarette company KanaVape, put pressure on the EC to change its decision in June to postpone the progress of CBD Novel Food applications as it decided whether to class non-synthetic CBD as a narcotic.

Cannabis is less dangerous? Not to me

The Straits Times Cannabis is less dangerous? Not to me, says Singaporean former drug addict A Singaporean former drug addict says the recent softening in stance by a UN commission towards marijuana, also known as cannabis, is cause for alarm. Jix Sze PublishedDec 24, 2020, 5:00 am SGT New: Gift this subscriber-only story to your friends and family https://str.sg/JRfy They can read the article in full after signing up for a free account. Share link: Or share via: Sign up or log in to read this article in full Sign up All done! This article is now fully available for you

MJ: MJ vs MSOS: Which Cannabis ETF is a Better Buy?

MJ) and AdvisorShares Pure US Cannabis ETF ( MSOS), have taken different strategies in pursuit of their targeted sector.  The Summit, New Jersey-based  ETFMG Alternative Harvest ETF (MJ) was founded in 2014 and targets the global cannabis industry by tracking the Prime Alternative Harvest Index. The top holding in its portfolio is its $10.03 share of Canada’s Aphria Inc. ( APHA), followed by an 8.43% share of Britain’s GW Pharmaceuticals plc ( The Bethesda, Maryland-based AdvisorShares Pure US Cannabis ETF (MSOS) only began trading on Sept. 2 of this year and concentrates solely on cannabis-related businesses within the U.S. market, investing at least 80% of its net assets in the securities of U.S. companies that derive at least half of their net revenue from marijuana and hemp businesses. Slightly more than half of its portfolio belongs to BlackRock Liquidity Funds Treasury Trust Institutional (

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.